The United States once led the world in running clinical trials that aimed to look like the nation at large. Now it is ...

However, the lack of diversity in these trials ... seated mistrust in medical institutions. While these historical events are painful reminders of systemic medical racism, today’s clinical ...

The diversity of clinical trial patients in the context of disease ... This is underpinned by historical mistrust in healthcare organisations, governments, and clinical research, which is still ...

For example, a DAP must be prepared for pivotal trials of a new drug, although, the regulator also recommends that sponsors develop a diversity strategy “across the entire clinical development ...

The removal of the FDA’s draft guidance on clinical trial diversity from the agency’s website, followed by its reappearance — with a note that the agency and administration “reject” it ...

A discussion on the impact of diversity, equity, and inclusion on nursing staff, patient care, clinical trial participation, and overall cancer care is presented.

A systematic review of randomized clinical trials (RCTs) on idiopathic inflammatory myopathies (IIMs) found that race was not appropriately reported in nearly half of the studies. A geographic ...

Accessing equitable health care is an ongoing struggle in the US for minority communities due to historical pretexts with new ...

The U.S., once a leader in diverse clinical trials, is reversing its initiatives under the Trump administration, causing ...

Trump's federal funding cuts are shutting down studies on Alzheimer’s care, uterine fibroids and pregnancy risks — all ...